Cargando…
WITHDRAWN: Remdesivir investigational trials in coronavirus disease 2019: a critical reappraisal()()
The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.nmni.2020.100745. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/...
Autores principales: | Brouqui, P., Giraud-Gatineau, A., Raoult, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276122/ https://www.ncbi.nlm.nih.gov/pubmed/32837727 http://dx.doi.org/10.1016/j.nmni.2020.100707 |
Ejemplares similares
-
Critical reappraisal of remdesivir investigational trials in COVID-19
por: Brouqui, P., et al.
Publicado: (2020) -
Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021) -
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
por: Montastruc, François, et al.
Publicado: (2020) -
Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022) -
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)